These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3080930)

  • 21. [Modification of plasma blood coagulation factor activity by physical stress].
    Lutze G; Buhl H; Häcker R; Socha C; Socha U; Urbahn H
    Z Gesamte Inn Med; 1986 Sep; 41(18):502-5. PubMed ID: 3099480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficiency and precision of electroimmunoassay for canine factor VIII-related antigen.
    Benson RE; Jones DW; Dodds WJ
    Am J Vet Res; 1983 Mar; 44(3):399-403. PubMed ID: 6404200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of a competitive enzyme immunoassay for factor VIII-related antigen].
    Riemer J; Kopperschläger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):72-83. PubMed ID: 6202602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
    Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor.
    Casonato A; Pontara E; Bertomoro A; Cattini MG; Soldera C; Girolami A
    Haematologica; 2003 Jun; 88(6):688-93. PubMed ID: 12801845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].
    Im T; Hintz G
    Arzneimittelforschung; 1986; 36(1):124-6. PubMed ID: 3082340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor VIII/von Willebrand factor in glomerular nephropathies.
    Coppola R; Guerra L; Ruggeri ZM; Tarantino A; Mannucci PM; Ponticelli C
    Clin Nephrol; 1981 Nov; 16(5):217-22. PubMed ID: 6796318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
    Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor VIII procoagulant antigen levels in normal pregnancy and preeclampsia.
    Lazarchick J; Stubbs TM; Romein LA
    Ann Clin Lab Sci; 1986; 16(5):395-8. PubMed ID: 3096191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease.
    Schwarz HP; Dorner F; Mitterer A; Mundt W; Schlokat U; Pichler L; Turecek PL
    Wien Klin Wochenschr; 1999 Mar; 111(5):181-91. PubMed ID: 10226348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced effect of exercise and DDAVP on factor VIII-von Willebrand Factor and plasminogen activator after sequential application of both the stimuli.
    Vicente V; Alberca I; Mannucci PM
    Thromb Haemost; 1984 Feb; 51(1):129-30. PubMed ID: 6426078
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of phospholipid on factor VIII coagulant activity and coagulant antigen.
    Brodén K; Brown JE; Carton C; Andersson LO
    Thromb Res; 1983 Jun; 30(6):651-60. PubMed ID: 6412394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoradiometric assays for factor VIII antigens: coagulant protein (antihemophilic factor) and factor VIII-related protein (von Willebrand factor).
    Hoyer LW; Trabold NC
    Methods Enzymol; 1982; 84():51-60. PubMed ID: 6808318
    [No Abstract]   [Full Text] [Related]  

  • 36. Factor VIII activity and factor VIII-related antigen in infants with viral bronchiolitis.
    Mazzone D; Fichera A; Praticò G; Sciacca F
    N Engl J Med; 1984 Nov; 311(19):1257-8. PubMed ID: 6436698
    [No Abstract]   [Full Text] [Related]  

  • 37. Increases in factor VIII complex and fibrinolytic activity are dependent on exercise intensity.
    Andrew M; Carter C; O'Brodovich H; Heigenhauser G
    J Appl Physiol (1985); 1986 Jun; 60(6):1917-22. PubMed ID: 3087936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?
    Greaves M; Pickering C; Knight G; Boulton AJ; Ball J; Ward JD; Preston FE
    Diabetologia; 1987 Mar; 30(3):160-5. PubMed ID: 3108060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of plasma factor VIII-correlating antigen in valve replacement patients].
    Weng WQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Jun; 13(2):93-4. PubMed ID: 3930194
    [No Abstract]   [Full Text] [Related]  

  • 40. Stability of von Willebrand factor and factor VIII in canine cryoprecipitate under various conditions of storage.
    Stokol T; Parry BW
    Res Vet Sci; 1995 Sep; 59(2):152-5. PubMed ID: 8525105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.